The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 361:1407-1410 October 1, 2009 Number 14
NextNext

Therapies for Type 2 Diabetes and Coronary Artery Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Boden, W. E.
-Related Article
 by The BARI 2D Study Group
-PubMed Citation
To the Editor: In the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial (ClinicalTrials.gov number, NCT00006305 [ClinicalTrials.gov] ) reported on by Frye and colleagues (June 11 issue),1 patient inclusion was based on a coronary anatomy that was suitable for revascularization. Thus, the results of this study are difficult to translate into clinical practice.

When evaluating a patient with chronic coronary artery disease, doctors must choose their strategy before catheterization. They may choose immediate catheterization with revascularization, if feasible (revascularization may not be suitable because of disease that is too diffuse or without relevant obstructions, as in the Trial of Invasive . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.